Rationale, Design, and Organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)
- 13 November 1997
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 80 (9), 54J-58J
- https://doi.org/10.1016/s0002-9149(97)00841-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart diseaseThe Lancet, 1997
- Beta-blocking agents in heart failure Should they be used and how?European Heart Journal, 1996
- The Management of Chronic Heart FailureNew England Journal of Medicine, 1996
- β-Adrenergic Blockers and Survival in Heart FailureNew England Journal of Medicine, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled studyJournal of the American College of Cardiology, 1994
- A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.Circulation, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990